The hospital is the second in the state and the first in the area to offer Percutaneous Transmural Arterial Bypass (PTAB) with DETOUR System. 

Trumbull Regional Medical Center is excited to announce a new treatment option for patients with complex Peripheral Artery Disease (PAD). By offering Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System, our team of experts can provide another option for patients with long lesions in their superficial femoral artery (SFA). We are proud to bring this innovative technology to our community and look forward to helping patients with complex PAD. In fact, Trumbull Regional is the first in the area and second in the state to offer this revolution procedure, with Ali Kimyaghalam, MD, Vascular Surgeon at Trumbull Regional Medical Center, completing the first procedure in the area on June 27, 2024.

The DETOUR System, which earned Breakthrough Device Designation from the FDA in 2020 and recently received approval from the FDA in June 2023, is designed specifically for patients with severe PAD in the superficial femoral artery (SFA). These patients include those who have long obstructions in the SFA, those with previously failed endovascular procedures, and those who may not be good candidates for surgical bypass. 

The development of the DETOUR System has been guided by data, including two multicenter, international studies. Clinical evidence demonstrates PTAB, using the DETOUR System, is an effective treatment option for patients with long complex SFA disease. 

“Our hospital is committed to providing the latest treatment options for our patients with PAD,” said Dr. Ali Kimyaghalam, Vascular Surgeon at Trumbull Regional Medical Center. “We are excited to offer PTAB with the DETOUR System, which can help provide an alternative treatment option for patients.”

For more information about PTAB with the DETOUR System, please contact Steward Heart and Vascular, Trumbull, at 330-841-9020 or visit trumbullregional.org.